Membrane Drug Transporters and Chemoresistance in Human Pancreatic Carcinoma
AbstractPancreatic cancer ranks among the tumors most resistant to chemotherapy. Such chemoresistance of tumors can be mediated by various cellular mechanisms including dysregulated apoptosis or ineffective drug concentration at the intracellular target sites. In this review, we highlight recent advances in experimental chemotherapy underlining the role of cellular transporters in drug resistance. Such contribution to the chemoresistant phenotype of tumor cells or tissues can be conferred both by uptake and export transporters, as demonstrated by in vivo and in vitro data. Our studies used human pancreatic carcinoma cells, cells stably transfected with human transporter cDNAs, or cells in which a specific transporter was knocked down by RNA interference. We have previously shown that 5-fluorouracil treatment affects the expression profile of relevant cellular transporters including multidrug resistance proteins (MRPs), and that MRP5 (ABCC5) influences chemoresistance of these tumor cells. Similarly, cell treatment with the nucleoside drug gemcitabine or a combination of chemotherapeutic drugs can variably influence the expression pattern and relative amount of uptake and export transporters in pancreatic carcinoma cells or select for pre-existing subpopulations. In addition, cytotoxicity studies with MRP5-overexpressing or MRP5-silenced cells demonstrate a contribution of MRP5 also to gemcitabine resistance. These data may lead to improved strategies of future chemotherapy regimens using gemcitabine and/or 5-fluorouracil.
5-fluorouracil; multidrug resistance proteins; S100A4; OATPs; nucleoside transporters; RNA interference
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Hagmann, W.; Faissner, R.; Schnölzer, M.; Löhr, M.; Jesnowski, R. Membrane Drug Transporters and Chemoresistance in Human Pancreatic Carcinoma. Cancers 2011, 3, 106-125.
Hagmann W, Faissner R, Schnölzer M, Löhr M, Jesnowski R. Membrane Drug Transporters and Chemoresistance in Human Pancreatic Carcinoma. Cancers. 2011; 3(1):106-125.Chicago/Turabian Style
Hagmann, Wolfgang; Faissner, Ralf; Schnölzer, Martina; Löhr, Matthias; Jesnowski, Ralf. 2011. "Membrane Drug Transporters and Chemoresistance in Human Pancreatic Carcinoma." Cancers 3, no. 1: 106-125.